Gary Quirke
Trustee 2001-2014
Appointed to the Trust Board in 2001, when he was Managing Director of P&O Nedlloyd, Gary Quirke’s extensive background in the commercial sector both in New Zealand and overseas made him a formidable and highly valued member of the Board’s Audit and Risk Committee. He was recognised as a Distinguished Trustee in 2021.
As a keen community fundraiser, he was also a member of the Advocacy Committee and worked with management to develop and implement fundraising strategies. When he stepped down from the Board in 2014, the institute was fortunate to retain him as a co-opted member of the Audit and Risk Committee, a position he continues to hold today.
Researchers explore 'RENTAL CAR' approach to CAR T-cell therapy
21 May 2026
Inside the Young Researchers Club: Supporting the next generation of scientists
11 May 2026
The science behind tomorrow's treatments
29 April 2026
National RNA Development Platform hits milestone with 500 products made for human, plant and animal health research
16 April 2026
Ground-breaking CAR-T clinical trial hits midway milestone
15 April 2026
From clinical trial to clinical tool: Bringing CAR-T to patients
26 March 2026